Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human galactocerebrosidase

EU orphan designation number: EU/3/11/911   
Active ingredient: Recombinant human galactocerebrosidase
Indication: Treatment of globoid cell leukodystrophy (Krabbe disease)
Sponsor: ACE BioSciences A/S
Roskildevej 12C, DK-3400 Hillerød, Danmark

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
29/09/2011 Centralised Orphan - Designation EMA/OD/042/11 (2011)7044 of 27/09/2011